查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1224522

mRNA合成材料的市场规模、份额和趋势分析报告:按类型(封端剂、核甘酸、质粒DNA)、应用、用途、地区、市场预测，2023-2030年

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

mRNA合成材料的市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球 mRNA 合成材料市场预计将达到 33 亿美元。 预计从 2023 年到 2030 年，复合年增长率将达到 2.1%。 市场增长的主要驱动力包括学术界和工业界对 mRNA 技术的兴趣增加、mRNA 疫苗的优越性以及研究经费的增加。 此外，预计在预测期内，越来越多的 RNA 技术治疗应用将为 mRNA 合成材料市场提供有利可图的机会。

COVID-19 大流行增加了对 mRNA 合成材料的需求，以开发有效的疫苗来对抗传染病。 mRNA 疫苗是预防 COVID-19 的安全有效方法。 此外，与 mRNA COVID-19 疫苗相关的好处引起了製药公司在全球范围内快速提供疫苗的兴趣。 例如，2020年3月，美国国家过敏和传染病研究所与Moderna Co., Ltd.联合开发了mRNA-1273（NIAID）。 因此，在 COVID-19 大流行期间，mRNA 疫苗的使用量显着增加。

此外，许多大型製药公司已开始研究基于 mRNA 的疗法，包括 Novartis、Alexion、AstraZeneca、Pfizer、Sanofi Pasteur 和 Shire。 例如，2022 年 1 月，根据辉瑞与 Acuitas Therapeutics 之间的开发和选择权协议，辉瑞可以选择许可 Acuitas 的 LNP 技术用于 mRNA 治疗和疫苗开发的多达 10 个目标。 因此，製药和生物技术公司对 mRNA 合成材料的采用率正在提高，进一步推动了市场的增长。

此外，由于 mRNA 的翻译是瞬时的，并且没有外来物质掺入细胞的基因组，由此产生的细胞治疗产品与传统方法获得的产品相比具有许多优势。这些包括在可接受的製造程序下易于製造、由于靶向和脱靶效应而降低的细胞毒性、临床验证和法规适应性。 因此，这些优势有望增加对 mRNA 疗法的需求，进一步推动市场增长。

此外，基于 mRNA 的技术已被证明在治疗和预防多种疾病方面具有令人难以置信的前景。 过去十年中技术和科学研究的重大进步使 mRNA 成为一种可行的治疗选择，克服了其较短的半衰期和固有的免疫原性，这些都是一些使用障碍。 例如，随着 mRNA 技术的进步，与新的过继性免疫疗法的融合可能会带来更安全、更有效的方法，例如产生最先进的嵌合抗原受体 T 细胞。 因此，预计 mRNA 技术的进步将为市场增长开闢新的途径。

然而，原材料的高成本可能会在研究期间阻碍市场。 例如，Cleancap AG 等原材料的采购价格约占两种疫苗生产过程中原材料总成本的 45%。 此外，围绕审批程序的监管框架一直是生物技术、製药和医疗技术行业最重要的抑制因素。 在中国和印度等 mRNA 合成材料市场具有巨大增长潜力的新兴国家，由于存在庞大的患者基数，因此缺乏针对治疗领域的有效监管框架/指南。预计将阻碍 mRNA 合成材料市场的增长年。

mRNA合成材料市场报告要点

到 2022 年，由于封端技术的进步及其在生物製药行业和研究中的应用，封端剂部分占比最大，达到 40.6%

按应用来看，2022年疫苗製造领域占比高达85.30%。 这归因于与使用容易失败的基于细胞培养的生产路线的传统疫苗相比，mRNA 疫苗的生产速度更快。

到 2022 年，北美将占据最高的收入份额，达到 35.5%。 这是由于主要参与者的存在、生物技术和製药公司已建立的商业基础设施的可用性以及该地区的高研发投资。

从终端用途来看，由于生物製药领域投资增加，管线增加，对mRNA合成材料的需求增加。2022年，生物製药和製药公司领域占据市场主导地位

目次

第 1 章调查方法及范围

  • 调查方法
  • 调查假设
  • 资讯采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
  • 资讯或数据分析
    • 数据分析模型
  • 市场制订和验证

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章市场变量、趋势和范围

  • 母市场分析
  • 市场动态
    • 市场促进因素分析
      • 学术界和工业界对 mRNA 技术的兴趣与日俱增
      • mRNA 疫苗的优势
      • 增加对 mRNA 研究的资助
    • 市场抑制因素分析
      • 没有针对基于 mRNA 的产品批准的有效政府法规
      • 用于 mRNA 合成的材料成本高
    • 市场问题分析
      • 缺乏经济实惠的长期製造工艺
  • 描绘采用情况和增长前景
  • mRNA 合成材料市场 - 波特分析
  • mRNA 合成材料市场 SWOT 分析
  • Covid-19 影响分析

第 4 章类型业务分析

  • mRNA 合成材料市场类型变化分析
  • 封盖剂
  • 核甘酸
  • 质粒DNA
  • 其他

第 5 章应用业务分析

  • mRNA 合成材料市场-应用的变化分析
  • 治疗药物的製造
  • 疫苗生产
  • 其他

第 6 章最终用户业务分析

  • mRNA 合成材料市场-最终用户差异分析
  • 生物製药和製药公司
  • Cros和Cmos
  • 学术研究机构

第 7 章区域业务分析

  • mRNA 合成材料市场：区域差异分析
  • 北美
    • SWOT 分析
    • 美国
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 加拿大
      • 主要国家动态
      • 竞争场景
      • 监管框架
  • 欧洲
    • SWOT 分析
    • 德国
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 英国
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 法国
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 意大利
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 西班牙
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 丹麦
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 瑞典
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 挪威
      • 主要国家动态
      • 竞争场景
      • 监管框架
  • 亚太地区
    • SWOT 分析
      • 亚太地区 mRNA 合成原材料，2018-2030 年（百万美元）
    • 日本
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 日本 mRNA 合成材料市场，2018-2030 年（百万美元）
    • 中国
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 2018-2030 年中国 mRNA 合成材料市场（百万美元）
    • 印度
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 印度 mRNA 合成材料市场，2018-2030 年（百万美元）
    • 澳大利亚
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 澳大利亚 mRNA 合成材料市场，2018-2030 年（百万美元）
    • 韩国
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 韩国 MRNA 合成材料市场，2018-2030 年（百万美元）
    • 泰国
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 泰国 mRNA 合成材料市场，2018-2030 年（百万美元）
  • 拉丁美洲
    • SWOT 分析
      • 拉丁美洲 mRNA 合成材料市场，2018-2030 年（百万美元）
    • 巴西
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 巴西 mRNA 合成材料市场，2018-2030 年（百万美元）
    • 墨西哥
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 墨西哥 mRNA 合成材料市场，2018-2030 年（百万美元）
    • 阿根廷
      • 主要国家动态
      • 竞争场景
      • 监管框架
      • 阿根廷 mRNA 合成材料市场，2018-2030 年（百万美元）
  • 中东和非洲
    • SWOT 分析
    • 南非
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 沙特阿拉伯
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 竞争场景
      • 监管框架
    • 科威特
      • 主要国家动态
      • 竞争场景
      • 监管框架

第 8 章竞争格局

  • 参加企业分类
    • F. Hoffmann - La Roche Ltd.
    • Jena Bioscience Gmbh
    • Merck KGaA
    • Yeasen Biotechnology (Shanghai) Co.,Ltd.
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai Lifesciences
    • New England Biolabs
    • Creative Biogene
    • Hongene
  • 财务业绩
  • 参赛者分类
    • 市场领导者
      • 2022 年 mRNA 合成原材料市场份额分析
    • 战略规划
      • 分机
      • 得到
      • 协作
      • 产品/服务发布
      • 伙伴关係
      • 其他
Product Code: GVR-4-68040-022-4

mRNA Synthesis Raw Materials Market Growth & Trends:

The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.1% from 2023 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights:

  • The capping agents segment held the largest share of 40.6% in 2022 owing to the advancements in the capping technology and their applications in the biopharma industry and research
  • By application, the vaccine production segment captured the highest share of 85.30% in 2022. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that use cell-culture-based production routes, which are often prone to failure
  • North America held the highest revenue share of 35.5% in 2022, due to the presence of key players, the availability of an established commercial infrastructure for biotechnology and pharmaceutical companies, and high research and development investments in the region
  • By end-user, the biopharmaceutical and pharmaceutical companies segment dominated the market in 2022 due to the increasing investments in the biopharmaceutical sector and the rising pipeline, which has boosted the need for mRNA synthesis raw materials

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Parent Market Analysis
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Growing Academic And Industrial Interest In mRNA Technology
      • 3.2.1.2 Advantages Of mRNA Vaccines
      • 3.2.1.3 Increasing Funding For mRNA Research
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Nonexistence Of Effective Government Regulations For mRNA - Based Product Approvals
      • 3.2.2.2 High Cost Of mRNA Synthesis Raw Materials
    • 3.2.3 Market Challange Analysis
      • 3.2.3.1 Lack Of Long - Lasting And Affordable Manufacturing Processes
  • 3.3 Penetration &Growth Prospect Mapping
  • 3.4 mRNA Synthesis Raw Materials Market - Porter's Analysis
  • 3.5 mRNA Synthesis Raw Materials Market - Swot Analysis
  • 3.6 Covid - 19 Impact Analysis

Chapter 4 Type Business Analysis

  • 4.1 mRNA Synthesis Raw Materials Market - Type Movement Analysis
  • 4.2 Capping Agents
    • 4.2.1 Global Capping Agents Market, 2018 - 2030 (USD Million)
  • 4.3 Nucleotides
    • 4.3.1 Global Nucleotides Market, 2018 - 2030 (USD Million)
  • 4.4 Plasmid Dna
    • 4.4.1 Global Plasmid Dna Market, 2018 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Global Other Types Market, 2018 - 2030 (USD Million)

Chapter 5 Application Business Analysis

  • 5.1 mRNA Synthesis Raw Materials Market - Application Movement Analysis
  • 5.2 Therapeutics Production
    • 5.2.1 Global Therapeutics Production Market, 2018 - 2030 (USD Million)
  • 5.3 Vaccine Production
    • 5.3.1 Global Vaccine Production Market, 2018 - 2030 (USD Million)
  • 5.4 Others
    • 5.4.1 Global Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6 End - User Business Analysis

  • 6.1 mRNA Synthesis Raw Materials Market - End User Movement Analysis
  • 6.2 Biopharmaceutical & Pharmaceutical Companies
    • 6.2.1 Global Biopharmaceutical & Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • 6.3 Cros & Cmos
    • 6.3.1 Global Cros & Cmos, 2018 - 2030 (USD Million)
  • 6.4 Academic And Research Institutions
    • 6.4.1 Global Academic And Research Institutions, 2018 - 2030 (USD Million)

Chapter 7 Regional Business Analysis

  • 7.1 mRNA Synthesis Raw Materials Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 Swot Analysis
      • 7.2.1.1 North America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 U.S. mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key country dynamics
      • 7.2.3.2 Competitive scenario
      • 7.2.3.3 Regulatory framework
      • 7.2.3.4 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Swot Analysis
      • 7.3.1.1 Europe mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 Germany mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.3 U.K.
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Uk mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 France mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.5 Italy mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Spain mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Denmark mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Competitive Scenario
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Sweden mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Key country dynamics
      • 7.3.9.2 Competitive scenario
      • 7.3.9.3 Regulatory framework
      • 7.3.9.4 Norway mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Swot Analysis
      • 7.4.1.1 Asia Pacific mRNA Synthesis Raw Materials, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Competitive Scenario
      • 7.4.2.3 Regulatory Framework
      • 7.4.2.4 Japan mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Regulatory Framework
      • 7.4.3.4 China mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Regulatory Framework
      • 7.4.4.4 India mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Competitive Scenario
      • 7.4.5.3 Regulatory Framework
      • 7.4.5.4 Australia mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Competitive Scenario
      • 7.4.6.3 Regulatory Framework
      • 7.4.6.4 South Korea mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Key country dynamics
      • 7.4.7.2 Competitive scenario
      • 7.4.7.3 Regulatory framework
      • 7.4.7.4 Thailand mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Swot Analysis
      • 7.5.1.1 Latin America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Regulatory Framework
      • 7.5.2.4 Brazil mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Regulatory Framework
      • 7.5.3.4 Mexico mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Key country dynamics
      • 7.5.4.2 Competitive scenario
      • 7.5.4.3 Regulatory framework
      • 7.5.4.4 Argentina mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Swot Analysis
      • 7.6.1.1 Mea mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 Key country dynamics
      • 7.6.2.2 Competitive scenario
      • 7.6.2.3 Regulatory framework
      • 7.6.2.4 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key country dynamics
      • 7.6.3.2 Competitive scenario
      • 7.6.3.3 Regulatory framework
      • 7.6.3.4 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 Key country dynamics
      • 7.6.4.2 Competitive scenario
      • 7.6.4.3 Regulatory framework
      • 7.6.4.4 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5 KUWAIT
      • 7.6.5.1 Key country dynamics
      • 7.6.5.2 Competitive scenario
      • 7.6.5.3 Regulatory framework
      • 7.6.5.4 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Participant's Overview
    • 8.1.1 F. Hoffmann - La Roche Ltd.
    • 8.1.2 Jena Bioscience Gmbh
    • 8.1.3 Merck KGaA
    • 8.1.4 Yeasen Biotechnology (Shanghai) Co.,Ltd.
    • 8.1.5 BOC Sciences
    • 8.1.6 Thermo Fisher Scientific, Inc.
    • 8.1.7 Maravai Lifesciences
    • 8.1.8 New England Biolabs
    • 8.1.9 Creative Biogene
    • 8.1.10 Hongene
  • 8.2 Financial Performance
  • 8.3 Participant Categorization
    • 8.3.1 Market Leaders
      • 8.3.1.1 mRNA Synthesis Raw Materials Market Share Analysis, 2022
    • 8.3.2 Strategy Mapping
      • 8.3.2.1 Expansion
      • 8.3.2.2 Acquisition
      • 8.3.2.3 Collaborations
      • 8.3.2.4 Product/service launch
      • 8.3.2.5 Partnerships
      • 8.3.2.6 Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 6 Global mRNA synthesis raw materials market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 11 U.S. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 14 Canada mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 17 Europe mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 21 Germany mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 22 Germany mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 24 U.K. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 25 U.K. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 26 U.K. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 27 France mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 28 France mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 29 France mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 30 Italy mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 31 Italy mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 32 Italy mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 33 Spain mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 34 Spain mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 35 Spain mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 36 Denmark mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 37 Denmark mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 39 Sweden mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 40 Sweden mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 42 Norway mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 43 Norway mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 44 Norway mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 49 Japan mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 50 Japan mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 51 Japan mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 52 China mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 53 China mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 54 China mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 55 India mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 56 India mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 57 India mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 58 South Korea mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 59 South Korea mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Korea mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 61 Australia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 62 Australia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 64 Thailand mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 65 Thailand mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 66 Thailand mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 67 Latin America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 68 Latin America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 69 Latin America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 71 Brazil mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 72 Brazil mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 74 Mexico mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 75 Mexico mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 76 Mexico mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 77 Argentina mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 84 South Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 90 UAE mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 93 Kuwait mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products/services
  • Table 102 Key companies undergoing partnerships
  • Table 103 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2022 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 mRNA synthesis raw materials market: Product outlook and key takeaways
  • Fig. 16 mRNA synthesis raw materials market: Product movement analysis
  • Fig. 17 Global capping agents market, 2018 - 2030 (USD Million)
  • Fig. 18 Global nucleotides market, 2018 - 2030 (USD Million)
  • Fig. 19 Global plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 20 Global other mRNA synthesis raw materials, by type market, 2018 - 2030 (USD Million)
  • Fig. 21 mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 22 mRNA synthesis raw materials market: Application movement analysis
  • Fig. 23 Global therapeutics production market, 2018 - 2030 (USD Million)
  • Fig. 24 Global vaccine production market, 2018 - 2030 (USD Million)
  • Fig. 25 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 26 mRNA synthesis raw materials market: End-use outlook and key takeaways
  • Fig. 27 mRNA synthesis raw materials market: End-use movement analysis
  • Fig. 28 Global biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 29 Global CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 30 Global academic & research institutions market, 2018 - 2030 (USD Million)
  • Fig. 31 mRNA synthesis raw materials market: Regional outlook and key takeaways
  • Fig. 32 North America: SWOT Analysis
  • Fig. 33 North America mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. key country dynamics
  • Fig. 35 U.S. mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe: SWOT Analysis
  • Fig. 39 Europe mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany key country dynamics
  • Fig. 41 Germany mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 France key country dynamics
  • Fig. 43 France mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 U.K. key country dynamics
  • Fig. 45 U.K. mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific: SWOT Analysis
  • Fig. 57 Asia Pacific mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 India key country dynamics
  • Fig. 61 India mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea key country dynamics
  • Fig. 63 South Korea mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Japan key country dynamics
  • Fig. 65 Japan mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Australia key country dynamics
  • Fig. 67 Australia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand key country dynamics
  • Fig. 69 Thailand mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America: SWOT Analysis
  • Fig. 71 Latin America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil key country dynamics
  • Fig. 73 Brazil mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Mexico key country dynamics
  • Fig. 75 Mexico mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina key country dynamics
  • Fig. 77 Argentina mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 MEA: SWOT Analysis
  • Fig. 79 MEA mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa key country dynamics
  • Fig. 81 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia key country dynamics
  • Fig. 83 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 UAE key country dynamics
  • Fig. 85 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait key country dynamics
  • Fig. 87 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Market participant categorization
  • Fig. 89 mRNA synthesis raw materials market share analysis, 2022
  • Fig. 90 Strategy framework